Glucagon-like insulinotropic peptide (GLP-1(7-37)) analogs and derivatives are disclosed. The analogs include amino acid substitutions, amino and carboxyl terminal modifications, and C₆-C₁₀ acylations. The claimed compounds stimulate the secretion or biosynthesis of insulin in poorly functioning beta cells and are therefore useful in treating Type II diabetics
本研究公开了胰高血糖素样促
胰岛素肽(GLP-1(7-37))类似物和衍
生物。这些类似物包括
氨基酸取代、
氨基和羧基末端修饰以及 C₆-C₁₀酰化。这些化合物能刺激功能不佳的β细胞分泌或
生物合成
胰岛素,因此可用于治疗 II 型糖尿病患者。